Brummel Kathleen E, Paradis Sara G, Butenas Saulius, Mann Kenneth G
Department of Biochemistry, University of Vermont, College of Medicine, Burlington, VT 05405, USA.
Blood. 2002 Jul 1;100(1):148-52. doi: 10.1182/blood.v100.1.148.
Tissue factor-induced blood coagulation was studied in 20 individuals, for varying periods of time during 54 months, in contact pathway-inhibited whole blood at 37 degrees C and evaluated in terms of the activation of various substrates. After quenching over time with inhibitors, the soluble phases were analyzed for thrombin-antithrombin III (TAT) complex formation, prothrombin fragments, platelet activation (osteonectin release), factor Va generation, fibrinopeptide (FP) A and FPB release, and factor XIII activation. TAT complex formation, for 35 experiments, showed an initiation phase (up to 4.6 +/- 0.6 minutes) in which thrombin was generated at an average rate of 0.93 +/- 0.3 nM/min catalyzed by about 1.3 pM prothrombinase yielding approximately 26 nM thrombin. During a subsequent propagation phase, thrombin was generated at a rate of 83.9 +/- 3.8 nM/min by about 120 pM prothrombinase, reaching ultimate levels of 851 +/- 53 nM. Clot time, determined subjectively, occurred at 4.7 +/- 0.2 minutes and correlated with the inception of the propagation phase. The thrombin concentrations associated with the transitions to rapid product formation are 510 +/- 180 pM for platelet activation (1.9 +/- 0.2 minutes), 840 +/- 280 pM for factor XIII activation and factor Va generation (2.2 +/- 0.6 minutes), 1.3 +/- 0.4 nM for FPA release (2.5 +/- 0.7 minutes), 1.7 +/- 0.5 nM for FPB release and prethrombin 2 (2.8 +/- 0.8 minutes), 7.0 +/- 2.2 nM for thrombin B chain (3.6 +/- 0.2 minutes), and 26 +/- 6.2 nM for the propagation phase of TAT formation (4.6 +/- 0.6 minutes). These results illustrate that the initial activation of thrombin substrates occurs during the initiation phase at less than 2 nM thrombin (0.2%). Most thrombin (96%) is formed well after clotting occurs.
在54个月的不同时间段内,对20名个体进行了组织因子诱导的血液凝固研究,在37℃下于接触途径抑制的全血中进行,并根据各种底物的激活情况进行评估。在用抑制剂随时间淬灭后,分析可溶性相中的凝血酶 - 抗凝血酶III(TAT)复合物形成、凝血酶原片段、血小板激活(骨连接蛋白释放)、因子Va生成、纤维蛋白肽(FP)A和FPB释放以及因子XIII激活。在35次实验中,TAT复合物形成显示出一个起始阶段(长达4.6±0.6分钟),在此阶段,凝血酶以平均0.93±0.3 nM/分钟的速率产生,由约1.3 pM的凝血酶原酶催化,产生约26 nM的凝血酶。在随后的传播阶段,凝血酶以83.9±3.8 nM/分钟的速率由约120 pM的凝血酶原酶产生,达到最终水平851±53 nM。主观确定的凝血时间为4.7±0.2分钟,与传播阶段的开始相关。与向快速产物形成转变相关的凝血酶浓度,对于血小板激活为510±180 pM(1.9±0.2分钟),对于因子XIII激活和因子Va生成是840±280 pM(2.2±0.6分钟),对于FPA释放为1.3±0.4 nM(2.5±0.7分钟),对于FPB释放和凝血酶原2为1.7±0.5 nM(2.8±0.8分钟),对于凝血酶B链为7.0±2.2 nM(3.6±0.2分钟),对于TAT形成的传播阶段为26±6.2 nM(4.±0.6分钟)。这些结果表明,凝血酶底物的初始激活发生在起始阶段,此时凝血酶浓度低于2 nM(0.2%)。大多数凝血酶(96%)在凝血发生后很久才形成。